Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
07 Jun, 2026, 06.51 AM IST
Eli Lilly’s obesity drug shows up to 30% weight loss in trialEli Lilly's new obesity drug retatrutide shows remarkable results. In a major trial, patients lost up to 30% of their body weight. This onc...
21 May, 2026, 10.28 PM IST
Iran war impact: Essential drugs may cost up to 5% more, for nowThe immediate net consumer impact could be 3-5% higher prices, or roughly similar to what consumers paid before the late-September cuts in ...
15 Apr, 2026, 06.00 AM IST
India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership roleIndia Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...
13 Apr, 2026, 12.59 PM IST
Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
13 Apr, 2026, 07.23 AM IST
Jhunjhunwalas-backed IKS healthcare looks to acquire TruBridge for $600 millionInventurus Knowledge Solutions (IKS), backed by the family of late investor Rakesh Jhunjhunwala, is in advanced talks to acquire Nasdaq-lis...
13 Apr, 2026, 07.01 AM IST
India is well positioned to attract future investments, says Eli Lilly's Patrik JonssonEli Lilly's Patrik Jonsson urges India to accelerate regulatory review pathways to boost competitiveness, emphasizing the need for data pro...
22 Mar, 2026, 12.54 PM IST
India is well positioned to attract future investments: Patrik Jonsson, President, Lilly InternationalEli Lilly's Patrik Jonsson urges India to accelerate regulatory review pathways to boost competitiveness, emphasizing the need for stronger...
22 Mar, 2026, 08.53 AM IST
'Chinese peptides' are the latest biohacking trend in the tech worldTech professionals are embracing unapproved Chinese peptides for weight loss, fitness, and productivity. These substances, often sourced di...
04 Jan, 2026, 05.30 AM IST
Weight-loss treatment: How has obesity medicine market become battleground for pharma giants like Pfizer, AstraZeneca, Eli Lilly?Obesity, weight-loss medicines: Novo has been scrambling to keep pace in the obesity drug race it started, losing ground to rival Eli Lilly...
11 Nov, 2025, 03.29 PM IST
Hot Stocks: 3 stocks that may give returns between 13-43%Analysts predict significant upside for select stocks, with potential returns ranging from 13% to 43%. Divi's Laboratories is poised to ben...
25 Apr, 2025, 05.58 AM IST
Eli Lilly's goal is to reach everyone who needs obesity care: Global CEO David RicksEli Lilly's CEO David Ricks discusses the launch of diabetes and anti-obesity drugs Mounjaro and Zepbound, focusing on expanding access in ...
26 Mar, 2025, 12.14 AM IST
Novo Nordisk inks $2-billion obesity drug deal with United LabsNovo will pay Hong Kong-based United Laboratories $200 million upfront for the drug, which combines three different mechanisms in an effort...
25 Mar, 2025, 01.08 AM IST
What can a wonder drug maker and a phone maker have in common? Their fall from graceNovo Nordisk's reign as Europe's most valuable company is facing a challenge from US rival Eli Lilly. Lilly's weight-loss drug, Zepbound, i...
21 Dec, 2024, 01.55 PM IST
Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in IndiaDoctors say patients come with specific queries regarding weight-loss drugs, which have become both the first preference and the last resor...
28 Apr, 2024, 08.50 AM IST
What other health conditions might weight-loss drugs treat?New data suggests that semaglutide may also cut the risk of stroke or heart attack, and may delay the progression of kidney disease in diab...
02 Jan, 2024, 05.13 PM IST